Navigation Links
TomoTherapy sees sustained market advantage

Madison, Wis. - Fred Robertson doesn't pretend to be a fortune teller, but he believes his company, TomoTherapy, will be setting the standard in radiation therapy for some time to come.

Robertson, chief executive officer of TomoTherapy, exudes confidence that the Hi-Art System, the company's radiation therapy platform, will continue to be a ......

Full article >>> ully shaping a radiation beam with IMRT or intensity modulated radiotherapy is only a piece of the puzzle. It is just as important to know where you are delivering that beam as it is to be able to shape the beam to conform to the tumor.

The progression

That hardware platform establishes a CT scanning base that should enable a host of additional software applications. Today......

Full article >>> ibilities.

The markets that are most appealing also happen to be in two of the world's fastest-growing economies - India and China. According to Robertson, the radiation oncology market is in varying stages of maturity, and one of the key metrics is the number of linear accelerators, devices widely used in radiotherapy, per million people. That number is 13 in the United States, but it's ......

Full article >>> out worrying about the pressures of Wall Street."

......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 12/11/06


Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. TomoTherapy opens technical training center
3. TomoTherapy raises $223 million in IPO
4. TomoTherapy revises IPO money target
5. Hospital named for Madame Curie installs TomoTherapy system
6. TomoTherapy files registration statement for IPO
7. TomoTherapy to sell medical devices in India
8. TomoTherapys 100th radiology system reaches public sector
9. TomoTherapy extends reach to Germany
10. Cash-rich TomoTherapy has no plans for IPO
11. City of Hope adds second TomoTherapy system
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... LOS ANGELES , Feb. 23, 2017  Capricor Therapeutics, ... cardiac and other medical conditions, today announced that Linda Marbán, ... at two upcoming investor conferences: Cowen ... 2017 at 10:00 am ET Boston, MA ... 14, 2017 at 9:00 am PT (12:00 pm ET) ...
(Date:2/23/2017)... and SAN FRANCISCO , Feb. 23, ... medicine company, and Beyond Type 1, a not-for-profit advocacy ... diabetes, today announced a grant from Beyond Type 1 ... for type 1 and other insulin-requiring diabetes.  ... developing innovative stem cell-derived cell replacement therapies with a ...
(Date:2/22/2017)... LEAWOOD, Kan. , Feb. 22, 2017  Aratana Therapeutics, ... licensing, development and commercialization of innovative biopharmaceutical products for companion ... 14, 2017 at 8:30 a.m. ET to discuss financial results ... 2016. Interested participants and investors may access ... dial-in: ...
(Date:2/22/2017)... ... February 22, 2017 , ... Park Systems , ... AFM Luncheon for all SPIE attendees and Park customers on Feb. ... block from the San Jose Convention Center. The luncheon will feature a talk ...
Breaking Biology Technology:
(Date:2/8/2017)... Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion in ... a compound annual growth rate (CAGR) of 24.0% through 2021. ... for synthetic biology. - Analyses of global market trends, with ... annual growth rates (CAGRs) through 2021. - Coverage of core ...
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... 2021 from $8.3 billion in 2016 at a compound ... 2021. Report Includes - An overview of the ... trends, with data from 2015 and 2016, and projections ... Segmentation of the market on the basis of product ...
(Date:2/7/2017)... Ind. , Feb. 7, 2017 Zimmer ... leader in musculoskeletal healthcare, will present at the LEERINK ... New York Palace Hotel on Wednesday, February 15, 2017 ... live webcast of the presentation can be accessed at ... replay following the conference via Zimmer Biomet,s Investor Relations ...
Breaking Biology News(10 mins):